Vertex Ventures HC

📢 We are pleased to announce that Merck (NYSE: MRK) has completed the acquisition of our portfolio company, EyeBio, for up to $3 billion.    This outcome is a testament to the dedication and brilliance of the EyeBio team, led by David Guyer (Co-founder, President & Chief Executive Officer) and Tony Adamis (Co-founder, Chief Scientific Officer).    EyeBio’s lead candidate, Restoret™, is scheduled to advance into a pivotal Phase 2b/3 trial to evaluate its potential for the treatment of patients with diabetic macular edema in the second half of 2024.    This acquisition is a significant win for patients, the ophthalmology field, and the investment community. Congratulations to everyone involved in this incredible journey!👏   Read more: https://lnkd.in/eRdnnxBZ Christine Brennan Lori Hu Sahil Chopra Amanda Chen #eyecare #opthalmology #biotech #acquisition #lifesciences #biopharma

📣  Are you passionate about innovation in the #biotech space? Join us for a FREE webinar and dive into the exciting world of Venture Capital and the Vertex Ventures HC Fellowship program! In this webinar, you'll discover: ✅ VC 101: Demystify the world of venture capital and understand how it funds promising #healthcare #startups ✅ Vertex Ventures HC Overview: Learn about Vertex Ventures HC, our #investment focus areas, and diligence/investment process ✅ Fellowship Program: What to expect in our Venture Fellowship program and process ✅ Q&A: Ask us anything! This webinar is perfect for: 🌟 Aspiring biotech #entrepreneurs and #innovators 🌟 Recent graduates and early-career professionals 🌟 Anyone interested in learning about Venture Capital and its role in life sciences Don't miss out on this chance to: 👉 Gain valuable insights from industry experts. 👉 Learn how the Vertex Ventures HC Fellowship program can propel your career in the biotech sector. 📅 Date: 14 Jun 2024 🕑 Time: 11 AM PST / 2 PM EST Panelists: - Lori Hu, Managing Director at Vertex Ventures HC - Amanda Chen, Senior Associate at Vertex Ventures HC - Sneha Batheja, Investor at The John Hopkins University and Former VVHC Fellow 👇 Space is limited, so register today at: https://lnkd.in/dwfwJxNz  #venturecapital #biotech #lifesciences #startup #medtech #womeninbiotech #womeninlifesciences #womenintech #diversity #womentechleaders #VC Venture Forward BLCK VC Black Venture Capital Consortium (BVCC) Chicago:Blend Diversity VC Girls Into VC Girls Who Invest Hack.Diversity HBCUvc LGBT+ VC Management Leadership for Tomorrow PledgeLA SomosVC StartOut VCFamilia Global Women in VC Women Who Launch

📣 Calling all aspiring #healthcare #investors!   Are you passionate about bringing groundbreaking innovations to the healthcare industry? Curious about the exciting world of venture capital (#VC) and how it fuels life-changing discoveries?   Join us for an exclusive FREE live Zoom webinar where we'll answer your questions about the Vertex Ventures HC #Venture #Fellowship program.   In this webinar, you'll learn: ✅ VC 101: Demystify the world of venture capital, understand how it funds promising healthcare startups and careers in VC ✅ Vertex Ventures HC Overview: Learn about Vertex Ventures HC, our investment focus areas, and diligence & investment process ✅ Fellowship Program: What to expect in our Venture Fellowship program and process ✅ Q&A: Ask us anything!   This webinar is perfect if you're an aspiring VC investor interested in a career in VC 🎓   Don't miss this chance to: 🌟 Learn what VCs are looking for in terms of background and experience 🌟 Get advice for building your network, getting your foot in the door, and interviewing for venture capital roles   Panelists: - Lori Hu, Managing Director at Vertex Ventures HC - Amanda Chen, Senior Associate at Vertex Ventures HC - Sneha Batheja, Investor at The John Hopkins University and Former Vertex Ventures HC Fellow   📅 Friday June 14, 2024: 2PM EST / 11AM PST 🔗 Register today at: https://lnkd.in/dwfwJxNz  #VentureCapital #Startup #Investing #CareerOpportunity #Webinar #VentureFellowship #Networking #ProfessionalDevelopment #WomeninVC

We are thrilled to announce a major exit in our portfolio. Only 7 months after VVHC led the Series A extension to invest in EyeBio, the Company has signed an agreement to be acquired by Merck for $1.3 billion upfront, with a total consideration of up to $3 billion.    This successful exit validates VVHC’s investment strategy, which is built upon a patient benefit and value creation-driven approach: ➡️ A focus on companies with deep management expertise, such as EyeBio co-founders, CEO David Guyer and CSO Tony Adamis, who along with the rest of the team, are developing therapies for patients still not served or underserved by existing therapies. ➡️ Along with excellent investment partners exemplified by the EyeBio syndicate: SV Health Investors, Samsara BioCapital, Jeito Capital, MRL Ventures Fund LLC, Omega Funds and Bain Capital Life Sciences.    Congratulations to the entire EyeBio team for this amazing outcome. We look forward to monitoring the development of Restoret™ for the treatment of diabetic macular edema and neovascular age-related macular degeneration, as well as the rest of the EyeBio pipeline. https://lnkd.in/erazsGCB Lori Hu Christine Brennan Sahil Chopra Amanda Chen

👩💼 Looking for your dream job? We're thrilled to introduce our brand new job board – your ultimate destination for #career opportunities!   Whether you're a seasoned professional or just starting out, discover a plethora of job listings from our portfolio companies.    ➡️ Don't miss out on your next big opportunity! Visit our website to start browsing now: https://lnkd.in/gmc94cm9 Lori Hu Christine Brennan Sahil Chopra Amanda Chen   #CareerOpportunities #Biotechtalent #Hiring

🎉🌟 Congratulations to our incredible team members for being featured on the prestigious 2024 Biomarker List! 🌟🎉 We're thrilled to share that Sahil Chopra and Amanda Chen have been recognized as rising stars in #biotech investing and creation. Their dedication, expertise, and innovative contributions continue to push the boundaries of scientific progress and shape the future of the industry. We're incredibly proud of their achievements and grateful for the invaluable insights they bring to our team. Interested in the #Biotech #VC space? Check out this annual resource for aspiring #investors and #entrepreneurs: https://lnkd.in/gP_X4qW6   Join us in congratulating them! 🚀🔬 #BiotechStars #Innovation #TeamSuccess

Congratulations SpyGlass Pharma, Inc. on achieving their groundbreaking milestone! 🌟

#ICYMI 🚀 Boundless Bio has officially been listed on Nasdaq! 🎉   We’re thrilled to witness this significant milestone as Boundless Bio embarks on its new chapter to revolutionize cancer treatments for patients with oncogene amplified cancers.    Congratulations, and we are looking forward to the team propelling groundbreaking advancements in #oncology and paving the way for brighter futures! 🌟   Christine Brennan Lori Hu Sahil Chopra Amanda Chen #NasdaqListing #IPO #CancerResearch #OncogeneCancer #Biotech

🌟 Happy International Women's Day! 🌟 As we celebrate the incredible achievements of women around the world, let's take a moment to reflect on the importance of inclusivity and empowerment. At Vertex Ventures HC, we are committed to inspiring inclusivity through our initiatives that promote #genderequality and elevate the voices of women in #leadership. This includes having female representation in leadership positions, setting up our fellowship program and co-founding women #VC networking groups. On this International Women's Day, let's recommit ourselves to building a world where every female has the opportunity to fulfill her potential and thrive. Together, we can create a more inclusive and equitable society for all. 💐👩💪 Lori Hu Christine Brennan Sahil Chopra Amanda Chen #IWD2024 #InspiringInclusion #InternationalWomensDay #WomenInLeadership #WomenInBusiness #WomensHistoryMonth #DiversityInHealthcare #VentureCapital #InternshipOpportunity #WomenInFinance #InclusiveLeadership

📢 Interested in #healthcare venture investing and #entrepreneurship? We are looking for our next Venture Fellow!    At VVHC, we believe in investing in the next-generation of healthcare leaders to create a future that is more representative and diverse today. Our Fellowship program aims to offer MD and PhD graduates a broad range of exposure to early-stage science, clinical development, business operations, venture investing and portfolio management. We encourage women, under-represented minorities and any aspiring venture capitalists to apply.   ➡️ Join us and be a part of a collaborative team: https://lnkd.in/gT_sic-m #venturecapital #startup #biotech #lifesciences #medicaldevices Lori Hu Christine Brennan